A study published in JAMA Oncology found that regular aspirin use is linked to a reduced risk of colorectal cancer (CRC), particularly among individuals with less healthy lifestyles. The study analyzed data from the Nurses’ Health Study and Health Professionals Follow-Up Study, including 107,655 participants. It showed that regular aspirin users had a lower 10-year cumulative incidence of CRC, especially those with higher BMI and smoking habits. The findings suggest using lifestyle factors to identify individuals who may benefit most from aspirin for cancer prevention.
Keep Reading
Add A Comment